Document is current
Any future updates will be listed below
-
Authors
Peikert, Kevin
Federti, Enrica
Matte, Alessandro
Constantin, Gabriela
Pietronigro, Enrica Caterina
Fabene, Paolo Francesco
Defilippi, Paola
Turco, Emilia
Del Gallo, Federico
Pucci, Pietro
Amoresano, Angela
Illiano, Anna
Cozzolino, Flora
Monti, Maria
Garello, Francesca
Terreno, Enzo
Alper, Seth Leo
Glaß, Hannes
Pelzl, Lisann
Akgün, Katja
Ziemssen, Tjalf
Ordemann, Rainer
Lang, Florian
Brunati, Anna Maria
Tibaldi, Elena
Andolfo, Immacolata
Iolascon, Achille
Bertini, Giuseppe
Buffelli, Mario
Zancanaro, Carlo
Lorenzetto, Erika
Siciliano, Angela
Bonifacio, Massimiliano
Danek, Adrian
Walker, Ruth Helen
Hermann, Andreas
De Franceschi, Lucia http://orcid.org/0000-0001-7093-777X
-
Funding
Funding for this research was provided by:
NA advocay (2018-2020)
Zentrum für Regenerative Therapien Dresden
Else Kröner-Fresenius-Stiftung
Universität Rostock
Kurt-Eberhard-Bode-Stiftung für Medizinische und Naturwissenschaftliche Forschung
European Research Council (695714)
- License Information
-
More Information
Article History
Received: 14 February 2021
Accepted: 14 April 2021
First Online: 3 May 2021
Declarations
:
: KP has received funding from the Else Kröner Clinician Scientist Program (TU Dresden, Germany) and the MeDDrive grant of the Technische Universität Dresden, and the Rostock Academy for Clinician Scientists (RACS, University of Rostock, Germany). HG, LP, AM, FL, EF, GC, ECP RO, PFF, PDF, ET, FDG, PP, AA, AI, FC, MM, FG, ET, AMB, ET, IA, AI, MB, EL, AS, MB, AD AND RHW none. KA received honoraria for presentation and consulting service from Biogen Idec, Merck, Sanofi and Roche. TZ received honoraria for presentation and consulting service from Biogen, Bayer, Celgene, Novartis, Roche, Sanofi, Teva. He received additional financial support for research activities from BAT, Biogen, Novartis, Roche, Teva, and Sanofi Aventis. AH has received funding from the Federal Ministry of Education and Research (BMBF), the Helmholtz-Association, the Schilling-Stiftung, the “Innovationsfond des Gemeinsamen Bundenausschusses”. He has received honoraria for presentations, advisory boards, consultations from BIOGEN and Desitin. He has received royalties from Elsevier Press. He serves as an editorial board member of BMC Neurology. SLA has received research funding from the US DoD and Quest Diagnostics. He has received consultation fees from the Broad Institute, the Medical University of Vienna, and Quest Diagnostics. LDF has received research funding by Agios.
